|Articles|October 8, 2021

In case you missed it: Oct. 4 to Oct. 8

Here's what you missed this week.

This week's top articles included:

Alyssa Dweck, MD, on menopause products, her podcast, and more from NAMS 2021

Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Are you seeing a rise in STI cases?

People are being diagnosed with chlamydia and gonorrhea at a higher rate than ever before, according to the Centers for Disease Control and Prevention (CDC). Take the poll and let us know if you are seeing cases rise in your own practice.

Women with endometriosis have greater psychological and sexual distress, study finds

A study has found that women with a diagnosis of endometriosis have significantly greater depressive symptomatology, sexual distress, and catastrophizing than age-paired healthy women.

Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

At the North American Menopause Society's (NAMS) 2021 Annual Meeting, sexual health specialist Michael Krychman, MD sat down with Brooke Faught, NP to learn more about the Women's Institute for Sexual Health, her role on the Planning Committee, and her tips for talking trauma with patients.

NFID 2020-2021 flu season survey results show pregnant women remain unprotected

According to new survey data from the National Foundation for Infectious Diseases (NFID), 44% of U.S. adults are unsure or do not plan to get the flu vaccine during the 2021-2022 flu season. The results also showed nearly 1 in 4 (23%) of people at high risk for flu-related complications, such as pregnant women, did not plan to get vaccinated.

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related to this article

October 29th, 2026

Susan Reed, MD, on the future of menopause research and funding

Susan Reed, MD, on the need for menopause research funding, a clinical trials network, and studies in understudied groups and perimenopause.

October 29th, 2026

Chrisandra Shufelt, MD, on cardiovascular prevention at menopause

Chrisandra Shufelt, MD, on why menopause is a window for cardiovascular prevention and the risk factors OB/GYNs should assess.

October 28th, 2026

Matthew Nudy, MD, on estrogen and the cardiovascular system

Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.

October 28th, 2026

ACOG advises against GLP-1 receptor agonists during pregnancy

ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.

October 27th, 2026

Rhonda Voskuhl, MD, on estriol for cognitive symptoms of menopause

Rhonda Voskuhl, MD, on a case series in which estriol and progesterone improved self-reported cognition in menopausal women at 12 months.

October 27th, 2026

Multi-society framework ties cardiovascular risk to female life stages

Joint guidance from the AHA, AAP, ACOG, and SMFM organizes cardiovascular prevention for girls and women around 4 female life stages.

October 26th, 2026

Mind, Body, & the Pause: Menopause, brain fog, and screening gaps, with Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG

In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.